Literature DB >> 2675226

Leukocyte membrane adhesion proteins LFA-1, CR3 and p150,95: a review of functional and regulatory aspects.

T W Kuypers1, D Roos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2675226     DOI： 10.1016/0923-2494(89)90114-4

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  8 in total

1.  Tolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients.

Authors:  Xian-ping Li; Jing Li; Heng Yan; Bo Zhou; Bo-hua Li; Wei-zhu Qian; Sheng Hou; Hao Wang; Fei Hao; Ya-jun Guo
Journal:  Acta Pharmacol Sin       Date:  2012-07-16       Impact factor: 6.150

2.  IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.

Authors:  G M Walsh; A Hartnell; A J Wardlaw; K Kurihara; C J Sanderson; A B Kay
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

3.  Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.

Authors:  C Ricardo-Carter; M Favila; R E Polando; R N Cotton; K Bogard Horner; D Condon; W Ballhorn; J P Whitcomb; M Yadav; R L Geister; J S Schorey; M A McDowell
Journal:  Parasite Immunol       Date:  2013-12       Impact factor: 2.280

4.  Soluble Fc gamma receptor III in human plasma originates from release by neutrophils.

Authors:  T W Huizinga; M de Haas; M Kleijer; J H Nuijens; D Roos; A E von dem Borne
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

5.  An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.

Authors:  M A Hazlewood; D S Kumararatne; A D Webster; M Goodall; P Bird; M Daha
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab.

Authors:  Carlo Pincelli; Eric Henninger; Florence Casset-Semanaz
Journal:  Arch Dermatol Res       Date:  2006-09-21       Impact factor: 3.017

7.  Flow cytometric analysis and modeling of cell-cell adhesive interactions: the neutrophil as a model.

Authors:  S I Simon; J D Chambers; L A Sklar
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

8.  Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8.

Authors:  T W Kuijpers; B C Hakkert; M H Hart; D Roos
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.